Frequent and heterogenous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma
1998

Expression of p21 in Urothelial Carcinoma

Sample size: 124 publication Evidence: moderate

Author Information

Author(s): S Clasen, WA Schulz, C-D Gerharz, M-O Grimm, F Christophl, BJ Schmitz-Drager

Primary Institution: Heinrich-Heine-Universität

Hypothesis

The study investigates the expression of the cyclin-dependent kinase inhibitor WAF1/p21 in urothelial carcinoma and its association with tumor grade and stage.

Conclusion

The expression of p21 is frequently observed in low-grade, superficial urothelial carcinomas but is less common in muscle-invasive tumors.

Supporting Evidence

  • p21 expression was detected in 66% of pTa tumors and 47% of carcinomata in situ.
  • Statistical analysis showed significant differences in p21 expression between low-stage and muscle-invasive tumors.
  • Accumulation of p53 protein increased with tumor grade, while p21 expression was associated with lower grades.

Takeaway

This study found that a protein called p21 is often present in early-stage bladder cancers but not in more advanced ones.

Methodology

The study used immunohistochemistry and quantitative RT-PCR to analyze p21 expression in tumor samples.

Limitations

The study did not evaluate mutations in the WAF1/p21 gene in all tumors, and the sample size for RNA analysis was limited.

Participant Demographics

Patients treated for primary or recurrent bladder tumors at Heinrich-Heine University.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication